Hydroxy B12 – 1mg
An active intermediate form of vitamin B12
- Readily converted into active B12
- Promotes cardiovascular health
- Supports the nerves and detoxification
- Superior to conventional cyanocobalamin
$24.96 — or subscribe and save 20%
Vitamin B12 plays an essential role in red blood cell formation, cell metabolism, and nerve function. A deficiency in vitamin B12 has been identified as one of the risk factors for several conditions. Vitamin B12 (cobalamin) is one of the most complex vitamins in existence. It helps support the body’s nerve and blood cells health, provides methylation support, and helps make DNA, the genetic material in all cells.
Because the human body does not make vitamin B12 or store it for long periods of time, it is important to supplement with this vitamin in order to stay healthy. B12 deficiencies are particularly common among vegetarians, with one German study reporting that only 5.3% of vegetarians meet the recommended intake of B12. You can find B12 in animal-based foods, such as eggs, fish, meat, and poultry; items that have been fortified; and in supplements.
Vitamin B12 also helps support the body’s ability to rid itself of cyanide from low-level exposure from environmental toxins while delivering the essential benefits of vitamin B12, before the body can use it.
AOR´s Hydroxy B12 supplement harnesses the power of hydroxocobalamin, an active and useful form of B12, in a convenient lozenge.
Hydroxy B12 – 1mg is hydroxocobalamin, a unique form of vitamin B12, which is more readily converted into the coenzyme forms than conventional cyanocobalamin. This allows Hydroxy B12 to serve as an effective broad-spectrum form of vitamin B12.*
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Take one lozenge under the tongue daily with or without food, or as directed by a qualified health care practitioner.
Consult a health care practitioner before use if you are pregnant, lactating, have a medical condition, or are taking any medication. Keep out of reach of children.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Other Ingredients: xylitol, microcrystalline cellulose, hydroxypropyl cellulose, tapioca syrup, and sodium stearyl fumarate.
Ellis FR, Nasser S. A pilot study of vitamin B12 in the treatment of tiredness. Br J Nutr. 1973 Sep; 30(2): 277-83.
Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol. 1993; 31(2): 277-94.
Fortin JL, Desmettre T, Manzon C, Judic-Peureux V, Peugeot-Mortier C, Giocanti JP, Hachelaf M, Grangeon M, Hostalek U, Crouzet J, Capellier G. Source: Department of Emergency and Critical Care Medicine, Jean Minjoz University Hospital, Besançon, France. Cyanide poisoning and cardiac disorders: 161 cases. J Emerg Med. 2010 May;38(4):467-76.
Mushett C, Kelley K, Boxer G, Rickards J. Antidotal Efficacy of Vitamin B12a (Hydroxo-Cobalamin) in Experimental Cyanide Poisoning. Proc Soc Exp Biol Med. 1952 Oct; 81(1): 234-7.
Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med. 2001 Jun; 37(6): 635-41.
Smith AD, Duckett S. Cyanide, vitamin B-12, experimental demyelination and tobacco amblyopia. Br J Exp Pathol. 1965 Dec; 46(6): 615-22.
van Asselt DZ, Pasman JW, van Lier HJ, Vingerhoets DM, Poels PJ, Kuin Y, Blom HJ, Hoefnagels WH. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci. 2001 Dec;56(12):M775-9.
van Asselt DZ, de Groot LC, van Staveren WA, Blom HJ, Wevers RA, Biemond I, Hoefnagels WH. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998 Aug; 68(2): 328-34.